328 related articles for article (PubMed ID: 2839097)
1. Enhanced in vitro growth suppression of human glioblastoma cultures treated with the combination of recombinant fibroblast and immune interferons.
Vita JR; Edwalds GM; Gorey T; Housepian EM; Fetell MR; Guarini L; Langer JA; Fisher PB
Anticancer Res; 1988; 8(3):297-302. PubMed ID: 2839097
[TBL] [Abstract][Full Text] [Related]
2. Synergistic antiproliferative effects of human recombinant alpha 54- or beta ser-interferon with gamma-interferon on human cell lines of various histogenesis.
Schiller JH; Groveman DS; Schmid SM; Willson JK; Cummings KB; Borden EC
Cancer Res; 1986 Feb; 46(2):483-8. PubMed ID: 2416427
[TBL] [Abstract][Full Text] [Related]
3. Antitumor effects of alpha-interferon and gamma-interferon on a murine renal cancer (Renca) in vitro and in vivo.
Sayers TJ; Wiltrout TA; McCormick K; Husted C; Wiltrout RH
Cancer Res; 1990 Sep; 50(17):5414-20. PubMed ID: 2117482
[TBL] [Abstract][Full Text] [Related]
4. Effect of recombinant human fibroblast interferon and mezerein on growth, differentiation, immune interferon binding and tumor associated antigen expression in human melanoma cells.
Fisher PB; Hermo H; Solowey WE; Dietrich MC; Edwalds GM; Weinstein IB; Langer JA; Pestka S; Giacomini P; Kusama M
Anticancer Res; 1986; 6(4):765-74. PubMed ID: 2944474
[TBL] [Abstract][Full Text] [Related]
5. Modulation of interferon receptor expression during combination beta ser-interferon and gamma-interferon treatment of human colon carcinoma cells.
Schiller JH; Bushmeyer SM; Ruzicka FJ; Princler GL; Faltynek CR; Borden EC
Cancer Res; 1990 Jan; 50(1):26-31. PubMed ID: 2136700
[TBL] [Abstract][Full Text] [Related]
6. The synergistic influence of human interferon-gamma and interferon-alpha on suppression of hematopoietic progenitor cells is additive with the enhanced sensitivity of these cells to inhibition by interferons at low oxygen tension in vitro.
Broxmeyer HE; Cooper S; Rubin BY; Taylor MW
J Immunol; 1985 Oct; 135(4):2502-6. PubMed ID: 3928752
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of antiviral activity against hepatitis C virus in vitro by interferon combination therapy.
Okuse C; Rinaudo JA; Farrar K; Wells F; Korba BE
Antiviral Res; 2005 Jan; 65(1):23-34. PubMed ID: 15652968
[TBL] [Abstract][Full Text] [Related]
8. Regulation of the antigenic phenotype of human melanoma cells by recombinant interferons.
Giacomini P; Gambari R; Barbieri R; Nisticò P; Tecce R; Pestka S; Gustafsson K; Natali PG; Fisher PB
Anticancer Res; 1986; 6(5):877-84. PubMed ID: 2432832
[TBL] [Abstract][Full Text] [Related]
9. Induction of growth suppression and modification of gene expression in multi-drug-resistant human glioblastoma multiforme cells by recombinant human fibroblast and immune interferon.
Moulton TA; Jiang H; Guarini L; Fetell MR; Fisher PB
Int J Cancer; 1992 May; 51(3):373-8. PubMed ID: 1317362
[TBL] [Abstract][Full Text] [Related]
10. Effect of murine alpha-, beta-, and gamma-interferons in combination with alpha-difluoromethylornithine, an inhibitor of polyamine biosynthesis, on the tumor growth and metastasis of B16 melanoma and Lewis lung carcinoma in mice.
Sunkara PS; Bowlin TL; Rosenberger AL; Fleischmann WR
J Biol Response Mod; 1989 Apr; 8(2):170-9. PubMed ID: 2499664
[TBL] [Abstract][Full Text] [Related]
11. Efficient inhibition of in vivo human malignant glioma growth and angiogenesis by interferon-beta treatment at early stage of tumor development.
Hong YK; Chung DS; Joe YA; Yang YJ; Kim KM; Park YS; Yung WK; Kang JK
Clin Cancer Res; 2000 Aug; 6(8):3354-60. PubMed ID: 10955823
[TBL] [Abstract][Full Text] [Related]
12. IFN-beta inhibition of etoposide resistance acquisition in vitro: studies using a human glioblastoma cell line.
Ishihara H; Kajiwara K; Ohshita N; Kimura Y; Nishizaki T; Ito H
Anticancer Res; 1995; 15(2):283-7. PubMed ID: 7762995
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of mouse bladder tumor proliferation by murine interferon-gamma and its synergism with interferon-beta.
Ratliff TL; Kadmon D; Shapiro A; Jacobs AJ; Heston WD
Cancer Res; 1984 Oct; 44(10):4377-81. PubMed ID: 6432311
[TBL] [Abstract][Full Text] [Related]
14. Synergistic antitumor effects of a combination of interferons and retinoic acid on human tumor cells in vitro and in vivo.
Lindner DJ; Borden EC; Kalvakolanu DV
Clin Cancer Res; 1997 Jun; 3(6):931-7. PubMed ID: 9815768
[TBL] [Abstract][Full Text] [Related]
15. Suppression of human ribosomal protein L23A expression during cell growth inhibition by interferon-beta.
Jiang H; Lin JJ; Tao J; Fisher PB
Oncogene; 1997 Jan; 14(4):473-80. PubMed ID: 9053844
[TBL] [Abstract][Full Text] [Related]
16. Comparative analysis of the priming effect of human interferon-gamma, -alpha, and -beta on synergism with muramyl dipeptide analog for anti-tumor expression of human blood monocytes.
Utsugi T; Sone S
J Immunol; 1986 Feb; 136(3):1117-22. PubMed ID: 3079797
[TBL] [Abstract][Full Text] [Related]
17. In vitro growth inhibition of cisplatin-resistant human lung cancer cell lines by recombinant human tumor necrosis factor and/or recombinant human interferon-gamma by virtue of collateral sensitivity.
Hong WS; Saijo N; Sasaki Y; Shinkai T; Eguchi K; Sakurai M; Takahashi H; Nakano H; Nakagawa K; Twentyman PR
Jpn J Cancer Res; 1987 Nov; 78(11):1274-80. PubMed ID: 3121562
[TBL] [Abstract][Full Text] [Related]
18. Individual and combined tumoricidal effects of dexamethasone and interferons on human leukocyte cell lines.
Pan LY; Guyre PM
Cancer Res; 1988 Feb; 48(3):567-71. PubMed ID: 3121176
[TBL] [Abstract][Full Text] [Related]
19. Synergistic antitumor effects of tumor necrosis factor and gamma-interferon on human colon carcinoma cell lines.
Schiller JH; Bittner G; Storer B; Willson JK
Cancer Res; 1987 Jun; 47(11):2809-13. PubMed ID: 3105867
[TBL] [Abstract][Full Text] [Related]
20. Recombinant human interferon alpha enhancement of retinoic-acid-induced differentiation of HL-60 cells.
Kohlhepp EA; Condon ME; Hamburger AW
Exp Hematol; 1987 May; 15(4):414-8. PubMed ID: 3471521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
